| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:51 UTC |
|---|
| Update Date | 2022-03-07 02:51:54 UTC |
|---|
| HMDB ID | HMDB0015232 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Pimozide |
|---|
| Description | Pimozide, also known as orap or halomonth, belongs to the class of organic compounds known as diphenylmethanes. Diphenylmethanes are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups. Similarly to other typical antipsychotics pimozide has a high affinity for the Dopamine D2 receptor and this likely results in its sexual (due to prolactin hypersecretion) and extrapyramidal side effects as well as its therapeutic efficacy against the positive symptoms of schizophrenia. Pimozide is a drug which is used for the suppression of motor and phonic tics in patients with tourette's disorder who have failed to respond satisfactorily to standard treatment. It also has special neurologic indications for Tourette syndrome and resistant tics. Its use is advised against in individuals with people with either a personal or a family history of arrhythmias or torsades de pointes. Pimozide is a very strong basic compound (based on its pKa). Pimozide is a potentially toxic compound. However, patients who experience negative side-effects with the first line medications are typically given pimozide. Pimozide is used in its oral preparation in schizophrenia and chronic psychosis (on-label indications in Europe only), Tourette syndrome, and resistant tics (Europe, USA and Canada). |
|---|
| Structure | FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=CC=CC=C12)C1=CC=C(F)C=C1 InChI=1S/C28H29F2N3O/c29-22-11-7-20(8-12-22)25(21-9-13-23(30)14-10-21)4-3-17-32-18-15-24(16-19-32)33-27-6-2-1-5-26(27)31-28(33)34/h1-2,5-14,24-25H,3-4,15-19H2,(H,31,34) |
|---|
| Synonyms | | Value | Source |
|---|
| Halomonth | ChEBI | | Neoperidole | ChEBI | | Opiran | ChEBI | | Orap | ChEBI | | Pimozida | ChEBI | | Pimozidum | ChEBI | | Janssen brand OF pimozide | HMDB | | Pharmascience brand OF pimozide | HMDB | | Orap forte | HMDB | | ASTA medica brand OF pimozide | HMDB | | Antalon | HMDB |
|
|---|
| Chemical Formula | C28H29F2N3O |
|---|
| Average Molecular Weight | 461.5462 |
|---|
| Monoisotopic Molecular Weight | 461.227868975 |
|---|
| IUPAC Name | 1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one |
|---|
| Traditional Name | pimozide |
|---|
| CAS Registry Number | 2062-78-4 |
|---|
| SMILES | FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=CC=CC=C12)C1=CC=C(F)C=C1 |
|---|
| InChI Identifier | InChI=1S/C28H29F2N3O/c29-22-11-7-20(8-12-22)25(21-9-13-23(30)14-10-21)4-3-17-32-18-15-24(16-19-32)33-27-6-2-1-5-26(27)31-28(33)34/h1-2,5-14,24-25H,3-4,15-19H2,(H,31,34) |
|---|
| InChI Key | YVUQSNJEYSNKRX-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as diphenylmethanes. Diphenylmethanes are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Diphenylmethanes |
|---|
| Direct Parent | Diphenylmethanes |
|---|
| Alternative Parents | |
|---|
| Substituents | - Diphenylmethane
- Phenylbutylamine
- Benzimidazole
- Aralkylamine
- Fluorobenzene
- Halobenzene
- Aryl fluoride
- Aryl halide
- Piperidine
- N-substituted imidazole
- Azole
- Heteroaromatic compound
- Imidazole
- Tertiary aliphatic amine
- Tertiary amine
- Azacycle
- Organoheterocyclic compound
- Organonitrogen compound
- Organooxygen compound
- Amine
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Organofluoride
- Organohalogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 214 - 218 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.0017 g/L | Not Available | | LogP | 5.6 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 7.43 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 13.9259 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.57 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 38.1 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1993.9 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 257.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 234.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 189.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 327.4 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 619.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 561.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 151.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1365.5 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 557.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1533.2 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 419.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 400.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 297.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 211.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 7.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Pimozide,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)N(C2CCN(CCCC(C3=CC=C(F)C=C3)C3=CC=C(F)C=C3)CC2)C2=CC=CC=C21 | 3774.5 | Semi standard non polar | 33892256 | | Pimozide,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)N(C2CCN(CCCC(C3=CC=C(F)C=C3)C3=CC=C(F)C=C3)CC2)C2=CC=CC=C21 | 3251.4 | Standard non polar | 33892256 | | Pimozide,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)N(C2CCN(CCCC(C3=CC=C(F)C=C3)C3=CC=C(F)C=C3)CC2)C2=CC=CC=C21 | 4348.5 | Standard polar | 33892256 | | Pimozide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)N(C2CCN(CCCC(C3=CC=C(F)C=C3)C3=CC=C(F)C=C3)CC2)C2=CC=CC=C21 | 3931.9 | Semi standard non polar | 33892256 | | Pimozide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)N(C2CCN(CCCC(C3=CC=C(F)C=C3)C3=CC=C(F)C=C3)CC2)C2=CC=CC=C21 | 3401.1 | Standard non polar | 33892256 | | Pimozide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)N(C2CCN(CCCC(C3=CC=C(F)C=C3)C3=CC=C(F)C=C3)CC2)C2=CC=CC=C21 | 4364.0 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Pimozide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0ugi-1391000000-81a5491e04c0772aa266 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Pimozide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | MS | Mass Spectrum (Electron Ionization) | splash10-001i-4890100000-ff909df45204eac82c46 | 2014-09-20 | Not Available | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Pimozide , positive-QTOF | splash10-03fr-3945500000-63d831a19fe77286e9e1 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pimozide 90V, Positive-QTOF | splash10-0a4i-2900000000-c5c24c6004ad63c44b7b | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pimozide 75V, Positive-QTOF | splash10-0a4i-2900000000-4ec6383bd789926aace8 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pimozide 45V, Negative-QTOF | splash10-001i-0900000000-f7e5bc8b3118f019d29a | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pimozide 60V, Negative-QTOF | splash10-001i-0900000000-15ed37cc4150d726424f | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pimozide 60V, Positive-QTOF | splash10-0a4j-2900000000-4cb696b16013c21eaecc | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pimozide 45V, Positive-QTOF | splash10-054k-3922000000-3dece675311cfc7dcecb | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pimozide 15V, Positive-QTOF | splash10-03di-0000900000-a6c11637d319ae7e0d4b | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pimozide 30V, Positive-QTOF | splash10-03di-0001900000-e11e7746c656531d49c3 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Pimozide 90V, Negative-QTOF | splash10-001i-0900000000-a10c36c7b309fd6a144a | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pimozide 10V, Positive-QTOF | splash10-03di-0010900000-930a125974bd00e0c2eb | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pimozide 20V, Positive-QTOF | splash10-03dj-0292700000-2985b790e5501b39bbd6 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pimozide 40V, Positive-QTOF | splash10-00ks-2981100000-75644e2a4fa99f98d3bc | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pimozide 10V, Negative-QTOF | splash10-03di-0000900000-d214f454d376b4403edd | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pimozide 20V, Negative-QTOF | splash10-03e9-0410900000-0d1a6255c713f6209ad8 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pimozide 40V, Negative-QTOF | splash10-001i-2920000000-0b02fc753cd5d50662e6 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pimozide 10V, Positive-QTOF | splash10-03di-0000900000-1007eb55b47c59016fd5 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pimozide 20V, Positive-QTOF | splash10-03di-0001900000-6016ca53ea77d615c57c | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pimozide 40V, Positive-QTOF | splash10-03yj-2790700000-5ee4d094cbf2edb564c4 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pimozide 10V, Negative-QTOF | splash10-03di-0000900000-d24101b35641ce78a840 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pimozide 20V, Negative-QTOF | splash10-03xr-1000900000-a8261095a6ae4bd8e429 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Pimozide 40V, Negative-QTOF | splash10-001i-3911100000-2bfbcbf4417742b7624d | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|